News

Wegovy vs Mounjaro: Eli Lilly to launch full-dose pen device in India as obesity drug race heats up
With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...
India approves Eli Lilly’s Mounjaro KwikPen for diabetes and obesity, offering a novel dual-action therapy
India’s drug regulator has approved Eli Lilly and Company’s diabetes and obesity drug Mounjaro in a KwikPen presentation, the ...